Correlation Between Allarity Therapeutics and Kiromic Biopharma
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Kiromic Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Kiromic Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and Kiromic Biopharma, you can compare the effects of market volatilities on Allarity Therapeutics and Kiromic Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Kiromic Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Kiromic Biopharma.
Diversification Opportunities for Allarity Therapeutics and Kiromic Biopharma
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Allarity and Kiromic is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Kiromic Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiromic Biopharma and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Kiromic Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiromic Biopharma has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Kiromic Biopharma go up and down completely randomly.
Pair Corralation between Allarity Therapeutics and Kiromic Biopharma
Given the investment horizon of 90 days Allarity Therapeutics is expected to under-perform the Kiromic Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Allarity Therapeutics is 1.21 times less risky than Kiromic Biopharma. The stock trades about -0.26 of its potential returns per unit of risk. The Kiromic Biopharma is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 750.00 in Kiromic Biopharma on August 27, 2024 and sell it today you would lose (482.00) from holding Kiromic Biopharma or give up 64.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 31.85% |
| Values | Daily Returns |
Allarity Therapeutics vs. Kiromic Biopharma
Performance |
| Timeline |
| Allarity Therapeutics |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Allarity Therapeutics and Kiromic Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allarity Therapeutics and Kiromic Biopharma
The main advantage of trading using opposite Allarity Therapeutics and Kiromic Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Kiromic Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will offset losses from the drop in Kiromic Biopharma's long position.| Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |